| | COMPOUND: C07927 | |
Entry |
|
Name |
|
Formula |
C12H24N2O4
|
Exact mass |
260.1736
|
Mol weight |
260.33
|
Structure |
|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M03 MUSCLE RELAXANTS
M03B MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
M03BA Carbamic acid esters
M03BA02 Carisoprodol
D00768 Carisoprodol (JAN/USP/INN) <US>
USP drug classification [BR:br08302]
Skeletal Muscle Relaxants
Carisoprodol
D00768 Carisoprodol (JAN/USP/INN)
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG02029 Muscle relaxant
DG01974 Centrally acting muscle relaxant
DG01973 Carbamate muscle relaxant
D00768 Carisoprodol
Metabolizing enzyme substrate
DG01639 CYP2C19 substrate
D00768 Carisoprodol
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00768
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D00768
|
Other DBs |
|
KCF data |
ATOM 18
1 N1a N 21.0497 -15.2573
2 C7a C 22.2516 -14.5633
3 O7a O 23.4536 -15.2573
4 C1b C 24.6555 -14.5633
5 C1d C 25.8574 -15.2573
6 C1b C 27.0594 -14.5633
7 O7a O 28.2613 -15.2573
8 C7a C 29.4632 -14.5633
9 N1b N 30.6652 -15.2573
10 C1c C 31.8671 -14.5633
11 O6a O 22.2516 -13.1756
12 C1b C 25.8574 -16.6450
13 C1a C 25.8574 -13.6612
14 C1b C 27.0447 -17.3306
15 O6a O 29.4632 -13.1756
16 C1a C 31.8671 -13.1755
17 C1a C 33.0751 -15.2607
18 C1a C 27.0448 -18.7267
BOND 17
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 6 7 1
7 7 8 1
8 8 9 1
9 9 10 1
10 2 11 2
11 5 12 1
12 5 13 1
13 12 14 1
14 8 15 2
15 10 16 1
16 10 17 1
17 14 18 1
|
|
» Japanese version
|
|